z-logo
open-access-imgOpen Access
Outcomes of kidney transplantations in children weighing 15 kilograms or less: a retrospective cohort study
Author(s) -
Chiodini Benedetta,
Herman Jean,
Lolin Ksenija,
Adams Brigitte,
Hennaut Elise,
Lingier Pierre,
Mikhalski Dimitri,
Schurmans Thierry,
Knops Noël,
Wissing Karl M.,
Abramowicz Daniel,
Ismaili Khalid
Publication year - 2018
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/tri.13108
Subject(s) - medicine , basiliximab , retrospective cohort study , kidney transplantation , surgery , waiting period , cohort , transplantation , kidney , toxicology , biology
Summary Kidney transplantation ( KT ) is often delayed in small children because of fear of postoperative complications. We report early‐ and long‐term outcomes in children transplanted at ≤15 kg in the two largest Belgian pediatric transplant centers. Outcomes before (period 1) and since the introduction of basiliximab and mycophenolate‐mofetil in 2000 (period 2) were compared. Seventy‐two KT s were realized between 1978 and 2016: 38 in period 1 and 34 in period 2. Organs came from deceased donors in 48 (67%) cases. Surgical complications occurred in 25 KT s (35%) with no significant difference between the two periods. At least one acute rejection ( AR ) occurred in 24 (33%) KT s with significantly less patients experiencing AR during period 2: 53% and 12% in period 1 and, period 2 respectively ( P < 0.001). Graft survival free of AR improved significantly in period 2 compared with period 1: 97% vs. 50% at 1 year; 87% vs. 50% at 10 years post‐ KT ( P = 0.003). Graft survival tended to increase over time (period 1: 74% and 63% at 1 and 5 years; period 2: 94% and 86% at 1 and 5 years; P = 0.07), as well as patient survival. Kidney transplantation in children ≤15 kg remains a challenging procedure with 35% of surgical complications. However, outcomes improved and are nowadays excellent in terms of prevention of AR , patient and graft survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom